A study tracking long-term cerebrospinal fluid changes before the transition from normal cognition to mild cognitive impairment (MCI) in ApoE4 carriers revealed a lower Aβ42/Aβ40 ratio compared to non-carriers, suggesting amyloidopathy prior to symptom onset38. Here, APOE is linked to Cognitive impairment.